메뉴 건너뛰기




Volumn 9, Issue 1, 2002, Pages 83-88

Pathways of inflammatory activation in Alzheimer's disease: Potential targets for disease modifying drugs

Author keywords

Alzheimer's disease; Anti inflammatory drugs; Clinical studies; Cyclooxygenase 1 2; Microglia; Non steroidal anti inflammatory drugs; p38 mitogen activated protein kinase; Peroxisome proliferator activated receptor gamma

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 (2,6 DICHLOROPHENYL) 2 (2,4 DIFLUOROPHENYLTHIO)PYRIMIDO[1,6 B]PYRIDAZIN 6 ONE; 5 (4 PYRIDINYL) 4 (4 FLUOROPHENYL) 1 (4 PIPERIDINYL)IMIDAZOLE; AMYLOID; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; DICLOFENAC; IBUPROFEN; INDOMETACIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN RADICAL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENYLACETIC ACID DERIVATIVE; PREDNISONE; PROPIONIC ACID DERIVATIVE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; SB 242235; STEROID; TENIDAP; TEPOXALIN; THIAZOLE DERIVATIVE; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 0036230270     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867023371292     Document Type: Article
Times cited : (80)

References (93)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.